FOXO1 and Hyperglycemia: In conclusion, this study demonstrates that repression of transcriptional activity of FoxO1 by HDAC inhibitors ameliorates hyperglycemia in type 2 diabetic rats, as shown in Figure 8B. The downregulation of blood glucose levels coincided with decreased expression of gluconeogenic genes via FoxO1 acetylation.